RBC Capital analyst Gregory Renza maintains Pacira BioSciences (NASDAQ:PCRX) with a Outperform and lowers the price target from $80 to $76.
CME Group To Launch Micro E-Mini Nasdaq-100 And S&P 500 Monday, Tuesday, Wednesday And Thursday Weekly Options On February 13
CME Group, the world's leading derivatives marketplace, today announced it will expand its suite of weekly options expiries for its Micro E-mini Nasdaq-100 and S&P 500 futures
